Keytruda Pembrolizumab 100mg Sourcing MHRA Regulations and Immunotherapy Advancements in UK 2026
Author: Dr. Sarah Mitchell
On August 17, 2026, leading thoracic oncology networks in the UK reviewed patient access corridors for monoclonal antibody checkpoint inhibitors. Sourcing authentic options like Keytruda (Pembrolizumab) 100mg Injection is a vital step in maintaining treatment cycles for lung and breast cancer care.
At Onco Medicine, we specialize in validated cold-chain shipping of specialty biologicals directly to clinics and patients across the UK under MHRA guidelines.
PD-1 Target Mechanism in Immunotherapy
Pembrolizumab is a humanized monoclonal antibody that targets the programmed cell death-1 (PD-1) receptor on T-cells:
- T-cell Activation: Blocks PD-1 interactions with PD-L1/PD-L2 ligands on tumor cells, preventing cancer from escaping immune surveillance.
- Broad Indication: Used extensively in NSCLC, melanoma, and triple-negative breast cancer.
- Validated cold-chain: Biologics must be kept strictly at 2-8°C during transit.
MHRA Personal Sourcing Compliance in the UK
UK residents can legally import specialized therapies for personal use under MHRA import guidelines:
- UK Oncologist Prescription: Sourcing requires a prescription from a licensed UK oncologist.
- 3-Month Supply Cap: Shipments are limited to a maximum 3-month personal supply per delivery.
- Temperature Loggers: Deliveries use validated insulated containers with USB loggers to record temperature in transit.
Secure Professional Sourcing & Support
For inquiries regarding batch availability, legal clearance documentation, or pricing details, please reach out to our dedicated support desk at support@onco-medicine.com. You can also connect directly with a qualified pharmacist via our verified WhatsApp Support Line at +91 94275 19809.


